NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between January 3, 2024 and December 2, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.co ...

Ascendant Appoints New CEO: Shemina Jiwani to Lead Next Phase of Growth TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Ascendant, a leading provider of international payment solutions, has announced a change in its senior leadership. Shemina Jiwani has been appointed as Chief Executive Officer (CEO), effective immediately. In her new role, Shemina will oversee all strategic initiatives and operations, steering Ascendant into its next phase of innovation led growth. About Ascendant Ascendant is a leading global ...

Company Performance and Potential - Solventum, formerly 3M's Health Care division, has high-quality businesses that delivered consistent performance within 3M, but its separation has not lived up to potential, with current performance significantly lower than when it was part of 3M [2][3] - Solventum's shares are currently trading at $69, but Trian believes the company could be worth $140 by year-end 2027 if it restores performance to historical levels [1][12] - Solventum's profit margins have declined nearly unprecedentedly since the spin-off, with consensus estimates expecting a 425bps decline in its first full standalone year, making it a bottom decile performer [6][8] Historical Context and Spin-Off Analysis - Prior to the spin-off, 3M research analysts estimated Solventum would be valued at $33 billion, implying a share price more than double its current trading price [3] - Solventum was 3M's best-performing business, consistently the fastest-growing and highest-margin division, but as an independent company, it has struggled to maintain growth and margins [7] - The average mid-to-large cap spin delivered approximately +125bps and +160bps of margin expansion in the first and third full year following separation, while Solventum's margins have declined significantly [6][8] Strategic Recommendations - Solventum should focus on improving operating performance, portfolio actions, and prudent capital allocation to enhance value creation [1] - Simplifying Solventum's portfolio, particularly by addressing non-core segments like Dental Solutions, Health Info Systems, and Purification & Filtration, could improve focus and execution [10][12] - Divestitures of non-core businesses could accelerate deleveraging and enable value-enhancing capital allocation decisions, including dividends, share repurchases, and bolt-on M&A [12] Long-Range Plan and Shareholder Engagement - Trian has initiated dialogues with Solventum's management and board, urging the company to act with urgency to reverse declines and communicate a more ambitious Long-Range Plan (LRP) [4] - The LRP should aim to restore Solventum's performance to historical levels, with growth targets of 3% to 4% organically and EBIT margins of 26%-27%, similar to its performance within 3M [12] - Trian believes historical performance levels and spin-related opportunities should frame Solventum's operating targets and broader strategy [12]

NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the âClassâ ) who purchased or acquired the stock of BioAge Labs, Inc. (âBioAgeâ or the âCompanyâ ) (NASDAQ: BIOA) pursuant and/or traceable to the Companyâs registration statement for the initial public offering held on or about September 26, 2024. For more information, submit a form at BioAge Labs, Inc. Shareholder Class Action Lawsuit, email I ...

Boston, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Consumer365 has named Klaviyo the "Best Email Campaign Service of 2025â . This recognition underscores the platform's ability to harness data-driven strategies and deliver impactful email marketing solutions to businesses of all sizes. With a focus on user-centric features and scalable tools, Klaviyo continues to redefine how businesses connect with their audiences in an ever-evolving digital landscape. Top Email Marketing Service Klaviyo - Its ability to combine da ...

PLEASANTON, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- InkSpace Imaging, a leader in MRI coil innovation, today announced that the United States (US) Food and Drug Administration (FDA) has cleared InkSpace Imagingâs next-generation 1.5 Tesla (1.5T) 24-channel MR coil for Siemens Healthineers Magnetom MRI scanners. This new medical device is part of their industry-leading suite of MR coils designed to revolutionize the patient experience while enhancing efficiency in MRI scans and clinical diagnosis. Designed ...

Clayton Mason, Senior Director of Marketing of Saracen Casino Resort, expressed enthusiasm about the partnership: "Integrating QCI Chatalytics into our operations marks a significant step in our strategy to harness the power of AI. With advanced tools like the Robot button, Slot Copilot and Player Copilot, we can deliver a more tailored and efficient experience for our guests while gaining deeper insights into our gaming operations." Dr. Ralph Thomas, CEO of QCI, shared his vision for the collaboration: "We ...

NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Regeneron Therapeutics, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, inclusive. For more information, submit a form at Regeneron Therapeutics, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at palloc ...

NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ASP Isotopes Inc. ("ASP Isotopes Inc." or the "Company") (NASDAQ: ASPI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ASP Isotopes Inc. investors who were adversely affected by alleged securities fraud between October 30, 2024 and November 26, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/asp ...

NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Five9, Inc. ("Five9, Inc." or the "Company") (NASDAQ: FIVN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Five9, Inc. investors who were adversely affected by alleged securities fraud between June 4, 2024 and August 8, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/five9-inc-lawsuit-submission ...